Degenerative neurological diseases and arthritic joint disorders are two of the most frequent types of disease, widespread throughout the world, which can involve the adult and senile age groups with a frequency that increases exponentially with increasing age.
Many therapies are now available for the symptomatic and, at least in part, pathogenetic management of arthritic neuromuscular and degenerative diseases; however, many needs remain unmet, since many patients do not reach a satisfactory level of quality of life, despite the therapies they undergo, others cannot tolerate some of the proposed treatments.
In this context, the experience of German centres has led to the arrival in Italy today of two new therapeutic instruments, innovative in terms of their mechanism of action and extremely promising in terms of their effectiveness and safety profile.
The rationale of this meeting is aimed at identifying the areas of disease and the type of patient best suited to experiencing the potential benefits of TRM and the Stochastic Resonance Treadmill to clarify the mechanisms through the benefits of these treatments are expressed and to publicize the data in the literature and clinical experiences gained from the use of these devices in Germany and Italy.
The aim is to develop a greater awareness of the potential of treatment in the medical class and to affirm these new therapeutic aids in the daily clinical practice of treatment of neuromuscular and arthritic diseases.
